Digital Pathology Market: AI, Interoperability & Growth

Lede

The Digital Pathology Market is entering a pivotal phase as leading healthcare technology providers and laboratory networks accelerate innovation and adoption. Recent developments including Philips’ launch of a next-generation DICOM-enabled pathology scanner, its global technology leadership recognition, and Labcorp’s nationwide rollout of an AI-powered digital pathology platform with PathAI—collectively signal a shift toward standardized, scalable, and clinically integrated digital pathology ecosystems. These advancements highlight how interoperability, artificial intelligence (AI), and enterprise-wide digital workflows are redefining diagnostic infrastructure worldwide.

Philips Advances Digital Pathology with Interoperable Imaging

Philips recently introduced the Pathology Scanner SGi, the first system capable of native configurable DICOM JPEG and JPEG XL output. This advancement allows pathology images to be stored in standardized formats, reducing dependence on proprietary systems and enabling seamless integration across hospital IT networks.

Key features include:

• DICOM JPEG XL support: up to 50% smaller file sizes without compromising image quality.

• Enterprise readiness: simplified cloud storage, centralized archiving, and smoother AI integration.

• Clinical impact: facilitates faster diagnosis and collaboration among pathologists.

From our observations at Next Move Strategy Consulting, standardized imaging formats are becoming a critical factor for scaling digital pathology. Hospitals that adopt interoperable formats can share and analyze slides across multiple locations more efficiently, supporting AI adoption and multi-center research initiatives.

Global Recognition Validates Philips’ Leadership

Philips’ innovation has earned the Frost & Sullivan 2025 Global Enabling Technology Leadership Recognition, highlighting its integrated digital pathology ecosystem—from slide scanners to AI-enabled workflow management.

• Over 3,500 pathologists globally use Philips’ systems.

• More than 38 million slides have been scanned, demonstrating large-scale adoption.

• FDA 510(k) clearance ensures regulatory confidence for primary diagnosis in clinical settings.

We observe that Philips’ recognition reflects not only technological leadership but also successful large-scale deployment. Metrics such as global adoption and FDA approval indicate practical clinical value and reliability, which are key drivers of trust in digital pathology solutions.

Labcorp Expands AI-Powered Digital Pathology Platform

Labcorp is expanding its collaboration with PathAI, rolling out the AISight Dx platform nationwide. This AI-enabled system:

• Integrates digital slide management with computational pathology analysis.

• Enhances workflow efficiency, enabling faster and more consistent diagnoses.

• Supports enterprise-level scaling, critical for large hospital networks and multi-site labs.

Next Move Strategy Consulting observes that AI-powered digital pathology is increasingly viewed as a tool to augment pathologists rather than replace them. The integration of AI into routine workflows improves diagnostic accuracy, speeds up case review, and addresses growing demand in high-volume laboratory environments.

Next Move Strategy Consulting Perspective

Our research indicates that the Digital Pathology Market is entering a strategic growth phase, characterized by:

• Interoperability – Standard formats like DICOM allow cross-platform integration and collaborative diagnostics.

• AI adoption – Enhances diagnostic speed, consistency, and scalability.

• Enterprise deployment – Large lab networks and hospitals are investing in platform-centric digital pathology ecosystems.

Impact & Future Prospects:

• Digital pathology is poised to become a core pillar of precision medicine, enabling scalable data sharing, computational analysis, and remote collaboration.

• Standardization and AI integration are expected to reduce operational bottlenecks and improve patient outcomes.

• Growing partnerships between technology providers and diagnostic labs indicate a shift toward platform-centric diagnostic ecosystems rather than isolated technology deployments.

Overall, we observe that digital pathology is transitioning from experimental adoption toward mainstream clinical integration. Institutions embracing interoperable, AI-enabled, enterprise-scale solutions are likely to gain measurable advantages in workflow efficiency, diagnostic accuracy, and research capabilities.

Conclusion

The Digital Pathology Market is evolving beyond isolated innovations toward integrated, AI-powered, and standardized solutions. Philips’ scanner, Labcorp’s nationwide AI deployment, and industry recognition collectively demonstrate a market ready for large-scale adoption.

Next Move Strategy Consulting estimates that hospitals and diagnostic labs prioritizing interoperability, AI integration, and enterprise deployment will lead the market, shaping the future of pathology diagnostics and precision healthcare.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to providing strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more information please contact:

Next Move Strategy Consulting

5th Floor 867

Boylston St, STE 500,

Boston, MA 02116, U.S.

E-Mail: [email protected]

Direct: +1-857-758-5017

Website: www.nextmsc.com